2009년 한국 뇌졸중 진료지침에서 이차예방을 위한 항혈소판제 사용에 관한 내용의 부분 개정 = Focused Update of 2009 Korean Clinical Practice Guidelines for the Antiplatelet Therapy in Secondary Prevention of Stroke

다국어 초록 (Multilingual Abstract)

The aim of this update of Korean clinical practice guidelines for stroke is to provide timely evidence-based recommendations on the antiplatelet therapy in secondary prevention of stroke. Evidence-based recommendations are included for the use of antiplatelet agents for noncardioembolic stroke. Changes in the guidelines necessitated by new evidence will be continuously reflected in the new guideline.

참고문헌 (Reference)

1 "http://www.stroke.or.kr"

2 Collaborative overview of randomised trials of antiplatelet therapy-I, "Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists’ Collaboration" 308 : 81-106, 1994

3 Sacco RL, "PRoFESS Study Group. Aspirin and extended-release dipyridamole versus clopidogrel for recurrent stroke" 359 : 1238-1251, 2008

4 RCP, "National clinical guidelines for stroke"

5 "Japanese guidelines for the management of stroke"

6 Diener HC, "European Stroke Prevention Study 2. Dipyridamole and acetylsalicylic acid in the secondary prevention of stroke" 143 : 1-13, 1996

7 "European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008" 25 : 457-507, 2008

8 "European Stroke Initiative recommendations for stroke management. European Stroke Council, European Neurological Society and European Federation of Neurological Societies" 10 : 335-351, 2000

9 European Stroke Initiative Executive Committee; EUSI Writing Committee, "European Stroke Initiative Recommendations for Stroke Management-update 2003" 16 : 311-337, 2003

10 SIGN, "Assessment, investigation, immediate management and secondary prevention"

11 ESPRIT Study Group, "Aspirin plus dipyridamole versus aspirin alone after cerebral ischaemia of arterial origin (ESPRIT): randomised controlled trial" 367 : 1665-1673, 2006

12 Adams RJ, "American Heart Association; American Stroke Association. Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack" 39 : 1647-1652, 2008

13 Sacco RL, "American Heart Association; American Stroke Association Council on Stroke; Council on cardiovascular Radiology and Intervention; American Academy of Neurology. Guidelines for prevention of stroke in patients with ischemic stroke or transient ischemic attack: a statement for healthcare professionals from the American Heart Association/American Stroke Association Council on Stroke: co-sponsored by the Council on Cardiovascular Radiology and Intervention: the American Academy of Neurology affirms the value of this guideline" 37 : 577-617, 2006

14 Albers GW, "American College of Chest Physicians. Antithrombotic and thrombolytic therapy for ischemic stroke: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)" 133 : 630S-669S, 2008

15 "A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee" 348 : 1329-1339, 1996